Equipment Supplement Request for Purchasing Amersham Typhoon RGB Phosphorimager (for R35GM127134)
Equipment Supplement Request for Purchasing Amersham Typhoon RGB Phosphorimager (for R35GM127134)
批准号:
10386084
负责人:
ALEXANDER S MANKIN
金额:
$6.26万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2023-03-31
关键词:
Anti-Bacterial AgentsAntibiotic ResistanceAntibioticsAreaBacterial GenesBasic ScienceBindingBiomedical EngineeringCellsClinicalCodeEngineeringEquipmentEvolutionFree RibosomeGene Expression RegulationGenesGenomeGrowthHybridsInitiator CodonKnowledgeLaboratoriesMedicineOrganismPenetrancePeptidesPharmaceutical PreparationsPhysiologicalPlayProductionProtein BiosynthesisProtein Synthesis InhibitorsProteinsRNARNA, Ribosomal, 23SRegulationResearchRibosomal RNARibosomesRoleSpecificityStructureTestingTranslation InitiationTranslationsbaseexperimental studyfrontiergene productgenome-wideinducible gene expressioninhibitor/antagonistinsightoperationresearch studyresistance generesistance mechanismribosome profilingsynergismtooltrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ribosome plays the key role in protein synthesis and is one of the main targets for antibiotics that
inhibit the growth of bacterial cells. Several key aspects of the functions of the ribosome are not fully
understood and antibiotics could play a critical role in gaining insights into unknown facets of translation.
Our laboratory has been on the forefront of antibiotics research and studies of the functional role of
ribosomal RNA (rRNA). We have elucidated the binding modes and mechanisms of action of a number of
major classes of antibiotics. On the basis of our findings we have proposed the new concept of context- and
protein-specific action of several types of protein synthesis inhibitors. We have also unveiled the operations of
several resistance mechanisms and revealed the principles of regulation of expression of inducible antibiotic
resistance genes. In parallel with our studies of antibiotics, we have advanced the field of ribosome
engineering having constructed the first ribosome with inseparable subunits based on a hybrid of 16S-23S
rRNA, opening new experimental venues for basic research and bioengineering.
Building upon our expertise in antibiotics, gene regulation and ribosome engineering, we will now
advance these areas to principally new frontiers. Our future research will proceed in three main directions: 1)
We will dedicate our effort to advancing the concept of context-specificity of bacterial ribosomal inhibitors to
become applicable to the eukaryotic ribosome. By using ribosome engineering, structural analysis and
genome-wide tests, we will identify compounds capable of binding in the nascent peptide exit tunnel of the
eukaryotic ribosome and interfering with production of a subset of proteins. 2) Our antibiotic-enforced ribosome
profiling experiments led to an unexpected and exciting finding of internal translation initiation inside a number
of bacterial genes. We will analyze the physiological significance of internal initiation, test the production of the
`alternative' gene products, study the regulation of expression of the genes from two different start codons and
explore the evolutionary penetrance of this phenomenon. 3) The ribosome is believed to have originated in the
pre-protein RNA World. However, all the previous attempts to demonstrate the ability of protein-free rRNA to
catalyze peptide bond formation have been unsuccessful. We will use the synergy between ribosome
engineering and antibiotic studies to generate catalytically active rRNA core. Altogether, the proposed
directions of research should significantly advance the use of antibiotics as medicines and as tools for
exploring ribosome functions in protein synthesis and translation regulation. We will use the knowledge of
antibiotic action to expand our understanding of genome plasticity and gene coding and illuminate the critical
questions of the ribosome origin and evolution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action
-
批准号:10443921
-
项目类别:
-
资助金额:$45.43万
-
财政年份:2022
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action
-
批准号:10569098
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2022
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action
-
批准号:10436039
-
项目类别:
-
资助金额:$73.0万
-
财政年份:2021
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Exploiting antibiotics to understand the ribosome and translation
-
批准号:10366000
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2018
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Exploiting antibiotics to understand the ribosome and translation
-
批准号:9897557
-
项目类别:
-
资助金额:$36.36万
-
财政年份:2018
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Context-specific action of antibiotics targeting the catalytic center of the bacterial ribosome
-
批准号:9158354
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2016
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Context-specific action of antibiotics targeting the catalytic center of the bacterial ribosome
-
批准号:9332339
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2016
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Molecular mechanisms of action of macrolide antibiotics
-
批准号:8482422
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2013
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Molecular mechanisms of action of macrolide antibiotics
-
批准号:8640960
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2013
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Programmed translation arrest controlled by nascent peptides and antibiotics
-
批准号:8917273
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2012
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Inhibitors of Bacterial Protein Synthesis with Novel Modes of Action
-
批准号:8408750
-
项目类别:
-
资助金额:$3.99万
-
财政年份:2012
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Programmed translation arrest controlled by nascent peptides and antibiotics
-
批准号:8554368
-
项目类别:
-
资助金额:$29.24万
-
财政年份:2012
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Inhibitors of Bacterial Protein Synthesis with Novel Modes of Action
-
批准号:8507709
-
项目类别:
-
资助金额:$3.88万
-
财政年份:2012
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Programmed translation arrest controlled by nascent peptides and antibiotics
-
批准号:8422205
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2012
-
负责人:ALEXANDER S MANKIN
-
依托单位:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
-
批准号:7433903
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2007
-
负责人:ALEXANDER S MANKIN
-
依托单位:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
-
批准号:7634572
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2007
-
负责人:ALEXANDER S MANKIN
-
依托单位:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
-
批准号:7900588
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2007
-
负责人:ALEXANDER S MANKIN
-
依托单位:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
-
批准号:7318532
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2007
-
负责人:ALEXANDER S MANKIN
-
依托单位:
Antibiotic Hypersusceptibility Mutations in Bacteria
-
批准号:6843112
-
项目类别:
-
资助金额:$34.42万
-
财政年份:2002
-
负责人:ALEXANDER S MANKIN
-
依托单位:
RIBOSOMAL PEPTIDYL TRANSFERASE CENTER
-
批准号:6046307
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2000
-
负责人:ALEXANDER S MANKIN
-
依托单位:
海外基金